Plain-English translation of NCT05195658 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This trial is testing a new type of stent called the CGUARD โ a mesh-covered device designed to be placed in the carotid artery during emergency treatment for a specific type of acute stroke. The stroke happens when a blood clot blocks the carotid artery at the point where it splits into branches in the neck. The mesh design of this stent is meant to trap the clot material and prevent pieces from breaking off and traveling to the brain, which is a major risk with standard stents.
Large clots in the carotid artery at this junction are extremely dangerous and very difficult to treat โ standard clot-dissolving medications rarely work for these strokes. Current stent technology doesn't effectively contain the clot material, leading to high risk of complications. This trial exists to test whether the CGUARD's mesh design can safely and effectively treat this life-threatening stroke type better than existing options.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will receive emergency treatment involving a catheter-based procedure where doctors thread a thin tube through your blood vessels to place the CGUARD stent at the clot site in your carotid artery. This is done as an emergency intervention in the hospital. After the procedure, you will have follow-up visits that include imaging scans and clinical assessments as part of standard stroke care โ the study team will track how well the stent works and monitor your recovery.
AI-generated summary from trial data ยท Aug 9, 2026 ยท Not medical advice
Poland